Tag: Christopher Porter
Seaport Therapeutics secures $100M to harness Monash invention
Seaport Therapeutics, a biopharmaceutical company in the clinical stage, centred on an innovative drug delivery system initially created by researchers from Monash University, announced the completion of a Series A funding round, which raised USD 100 million (AUD 154 million).
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
